Wellemp® GLP-1 weight manegement slimming droplet

Wellemp® GLP-1 weight manegement slimming droplet

Global Obesity Crisis: Escalating Epidemic Phenomenon

Obesity is becoming increasingly prevalent worldwide. Taking the United States as an example, the obesity incidence has been continuously rising over the past 30 years, nearly doubling since the late 1970s. From 2017 to 2023, the national obesity rate among adults stood at 41.9%. Simultaneously, the obesity rate among adolescents was 19.7%.

A Groundbreaking Product, The Ultimate Answer To Weight Loss

Obesity results from a combination of factors, including reduced opportunities for physical activity, an increase in high-calorie foods, and genetic predisposition that may lead to weight gain. Ultimately, obesity stems from a prolonged intake of calories surpassing the body’s needs. Excess calories are stored in the body in the form of fat (adipose tissue).

The effectiveness of the GLP-1 Slimming Droplet lies in its dual-action approach, addressing intake and expenditure. On one hand, it suppresses appetite, aiding in reduced food consumption and subsequent weight loss. It also slows gastric emptying, prolonging the feeling of fullness over an extended period. On the other hand, it accelerates the body’s metabolism, promoting fat burning.

Key Ingredient ——GLP-1

Glucagon-like peptide-1 (GLP-1) is a peptide hormone produced by the L cells in the human intestinal tract. Its primary physiological functions include four key aspects:

1. Stimulating insulin secretion from pancreatic β-cells;
2. Inhibiting glucagon secretion from pancreatic α-cells;
3. Suppressing gastric motility, delaying gastric emptying;
4. Regulating energy balance through various pathways. For instance, it can stimulate regions in the hypothalamus and brainstem, impacting appetite and satiety. It also affects the metabolic functions of organs and tissues such as the pancreas, liver, and adipose tissue.

Dr. Korina: A Pioneer Dedicated to Solving Obesity Issues

Dr. Korina is a professor in the Department of Biochemistry and Medicine at Boston University School of Medicine. With over 40 years of dedicated research in the field of obesity and metabolism, she has held positions as the Chair of the American Society for Nutrition (ASN) and the Boston Nutrition Obesity Research Center (BNORC). Throughout her career, she has been honored with numerous accolades and awards.